Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS have been successful with 3 Clinical Trials (BioPatch, MANTIS and NINJA) being awarded.

BioPatch

NIHR i4i committee has approved Prof Andrew Carr’s application entitled “A novel electrospun patch to augment rotator cuff tendon repair” - Oxford BioPatch. The Oxford Biopatch is an innovative solution for rotator cuff repair which promotes rapid regrowth of tendon tissue and could transform the success of shoulder repair operations. Speaking about the award Prof Carr stated that “The monies from the NIHR are invaluable to investigate whether a nanofiber surgical patch invented in Oxford can improve the outcome of surgery for tendon repair in the shoulder and we are looking forward to discovering if the technology can improve patient recovery”.

MANTIS

NIHR HTA committee has approved Prof Sion Glyn-Jones application entitled “Managing Avascular Necrosis Treatments: An Interventional Study” MANTIS. This will be looking at the debilitating affect that Avascular Necrosis (AVN) of the hip occurs in younger people and how this may be managed by an effective drug treatment. Lead Researcher Prof Sion Glyn Jones states that “With this support from NIHR we have the opportunity to find an effective drug treatment for this condition could improve the quality of life for thousands of young people”

NINJA

NIHR RfPB committee has approved Prof Abhilash Jain and his application entitled “Nail Injury Analysis Trial” NINJA. This will be looking into childrens’ fingertip injuries which is the most common surgically treated paediatric hand injury with 10,000 operations performed every year in the UK. Despite this there are no published randomized controlled trials (RCT) looking at surgical interventions and NINJA is the first multi-centre RCT looking at ways to improve surgical outcomes in these patients. On receiving confirmation of the award Prof Jain stated “This award from NIHR will allow us to evaluate two differing repair techniques with the intention of advising best practice to clinicians for future Injuries”.

Our Team

Further Information on the Trials

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.